Oncolog-Hematolog.ro : Impact Factor & More
eISSN: 2066-8260pISSN: 2066-8716
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Oncolog-Hematolog.ro
Oncolog-Hematolog.ro Journal Specifications
| Overview | |
| Publisher | Medichub Media |
| Language | English |
| Publication Time | 8 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Romanian Society of Radiotherapy and Medical Oncology |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Oncolog-Hematolog.ro ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Oncolog-Hematolog.ro
Application of CRISPR-Cas9 technology in the treatment of chronic lymphocytic leukemia with P53 gene mutations
- 1 Jan 2026
- Oncolog-Hematolog.ro
Renal cancer: from biological heterogeneity to clinical decision-making
- 1 Jan 2026
- Oncolog-Hematolog.ro
Redefining the timing of palliative care initiation in advanced and metastatic cancer: from prognostic thresholds to needs-based concurrent integration along the therapeutic trajectory
- 1 Jan 2026
- Oncolog-Hematolog.ro
Therapeutic plasma exchange: a comprehensive evaluation of efficacy and outcomes in neurological and non-neurological disorders
- 1 Jan 2025
- Oncolog-Hematolog.ro
Quality of life for actively treated patients and for palliative care treated patients with cancer
- 1 Jan 2025
- Oncolog-Hematolog.ro
New extended investigations in breast cancer diagnosis, including miRNAs – short review
- 1 Jan 2025
- Oncolog-Hematolog.ro
Application of CRISPR-Cas9 technology in the treatment of chronic lymphocytic leukemia with P53 gene mutations
- 1 Jan 2026
- Oncolog-Hematolog.ro
Renal cancer: from biological heterogeneity to clinical decision-making
- 1 Jan 2026
- Oncolog-Hematolog.ro
Redefining the timing of palliative care initiation in advanced and metastatic cancer: from prognostic thresholds to needs-based concurrent integration along the therapeutic trajectory
- 1 Jan 2026
- Oncolog-Hematolog.ro
Therapeutic plasma exchange: a comprehensive evaluation of efficacy and outcomes in neurological and non-neurological disorders
- 1 Jan 2025
- Oncolog-Hematolog.ro
Quality of life for actively treated patients and for palliative care treated patients with cancer
- 1 Jan 2025
- Oncolog-Hematolog.ro
New extended investigations in breast cancer diagnosis, including miRNAs – short review
- 1 Jan 2025
- Oncolog-Hematolog.ro
FAQs on Oncolog-Hematolog.ro
How many articles did Oncolog-Hematolog.ro publish last year? 
What is the eISSN & pISSN for Oncolog-Hematolog.ro?
Who is the publisher of Oncolog-Hematolog.ro?
